ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : MARSUPIAL MODEL
Status : Closed
Clear All
Filter by Field of Research
Endocrinology (7)
Medical infection agents (incl. prions) (7)
Respiratory Diseases (7)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (5)
Medical and Health Sciences (5)
Nutritional science (5)
Oncology And Carcinogenesis (5)
Orthopaedics (5)
Medical biotechnology not elsewhere classified (4)
Reproduction (4)
Allergy (3)
Central Nervous System (3)
Haematology (3)
Medical bacteriology (3)
Oncology and Carcinogenesis (3)
Anaesthesiology (2)
Biochemistry and Cell Biology not elsewhere classified (2)
Dermatology (2)
Developmental Genetics (incl. Sex Determination) (2)
Emergency medicine (2)
Genetic Development (Incl. Sex Determination) (2)
Medical Genetics (excl. Cancer Genetics) (2)
Medical Virology (2)
Medical physiology not elsewhere classified (2)
Neurosciences not elsewhere classified (2)
Psychiatry (2)
Surgery (2)
Autoimmunity (1)
Biochemistry And Cell Biology Not Elsewhere Classified (1)
Biomedical Engineering not elsewhere classified (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (154)
Filter by Status
Closed (154)
Filter by Scheme
NHMRC Project Grants (154)
Filter by Country
Australia (9)
Filter by Australian State/Territory
NSW (4)
VIC (3)
SA (1)
WA (1)
  • Researchers (0)
  • Funded Activities (154)
  • Organisations (0)
  • Funded Activity

    The Retinal Pigment Epithelium Of The Quokka.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $220,095.00
    More information
    Funded Activity

    A Y CHROMOSOME MODEL FOR THE SEX DETERMINING FUNCTION OF THE HUMAN ATRX GENE

    Funder
    National Health and Medical Research Council
    Funding Amount
    $272,131.00
    Summary
    Human sex determination is controlled by a genetic pathway which culminates in the development of a testis or an ovary in the human embryo. At the head of this pathway is the master switch gene SRY on the Y chromosome, which controls a cascade of other genes critical for switching on testis development. Several other genes have been identified by clinical mutations which reverse sex of XY embryos. One sex reversing gene is ATRX on the human X chromosome. Mutation in ATRX causes XY embryos to dev .... Human sex determination is controlled by a genetic pathway which culminates in the development of a testis or an ovary in the human embryo. At the head of this pathway is the master switch gene SRY on the Y chromosome, which controls a cascade of other genes critical for switching on testis development. Several other genes have been identified by clinical mutations which reverse sex of XY embryos. One sex reversing gene is ATRX on the human X chromosome. Mutation in ATRX causes XY embryos to develop as females, as well as causing many unrelated disorders such as alpha-thalassemia. ATRX seems to be a transcription factor that controls the activity of other genes, but it is difficult to understand how it functions because it is active in all parts of the body and mutation has many different effects in humans. However, we recently discovered that in marsupial mammals that this gene has a copy on the Y chromosome (ATRY) as well as the X (ATRX). Remarkably, there is a division of labour between ATRY, which acts only in developing gonads, and ATRX, which is active everywhere else. This testis-specific ATRY gene may reveal how ATRX interacts with other genes to make a testis, without the complications of its action in other tissues. We will therefore clone and characterize ATRX-Y and its protein product to find out when and where it acts in the sex determining pathway. We will use very large cloned pieces of the marsupial genome to discover elements controlling the testis-specific expression, and we will identify the interactions of ATRY with other proteins. The testis determination pathway is a good model for the differentiation of other human organs. Our work on ATRY will show us how this class of transcription factors is activated in different tissues during development, and how it controls other genes. This will lead to a better understanding of the genetic control of human organogenesis and the effects of mutation on human development.
    Read more Read less
    More information
    Funded Activity

    How Is Maleness And Femaleness Determined

    Funder
    National Health and Medical Research Council
    Funding Amount
    $187,115.00
    More information
    Funded Activity

    How Important Is Collagen Destruction In Arthritis? A Study With Collagenase-resistant Knockin Mice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $529,723.00
    Summary
    Aggecan and collagen are important structural molecules in cartilage. Together they allow cartilage to bear weight and resist compression. In arthritis, collagen is degraded by collagenases and aggrecan is degraded by aggrecanases. Aggrecan loss is a feature of cartilage disease. Early aggrecan loss is well documented and usually precedes clinical symptoms, suggesting that it is the initiating step in cartilage pathology. Aggrecan loss precedes collagen damage in explant culture, however it is n .... Aggecan and collagen are important structural molecules in cartilage. Together they allow cartilage to bear weight and resist compression. In arthritis, collagen is degraded by collagenases and aggrecan is degraded by aggrecanases. Aggrecan loss is a feature of cartilage disease. Early aggrecan loss is well documented and usually precedes clinical symptoms, suggesting that it is the initiating step in cartilage pathology. Aggrecan loss precedes collagen damage in explant culture, however it is not known whether inhibiting aggrecanases is sufficient to block cartilage damage long-term. In contrast, other studies suggest that aggrecan is only lost after damage to the collagen scaffold. These studies propose that clipping of the collagen scaffold may initiate aggrecan release; with progressive degeneration and collagen clipping, more aggrecan is lost, until ultimately the scaffold is severely damaged and aggrecan is severely depleted. Cartilage can only withstand a limited degree of collagen degradation and any significant damage to the network is widely considered to be irreparable. It is unclear what role aggrecanases and collagenases have in initiating and perpetuating cartilage damage. We have mice with aggrecan resistant to aggrecanases and mice with inactive aggrecanase. We will also create mice with collagen resistant to collagenase. We will use these mice to determine the contribution of collagenases and aggrecanases to the initiation and progression of cartilage damage, in three models of joint disease. We will identify differences in time of disease onset, rate of disease progression and disease severity. The results will show whether one or both activities is important for the initiation and progression of joint disease. This will reveal whether single or combination therapies are required for the management of arthritis. The research will inform the pharmaceutical industry on directions for the development of new drugs to prevent joint disease.
    Read more Read less
    More information
    Funded Activity

    Monocytes/macrophages And Colony Stimulating Factors In A Murine Model Of Chronic Inflammatory Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $358,997.00
    More information
    Funded Activity

    An Analysis Of Cell Populations Recirculating Through N Ormal And Inflamed Joints In Vivo

    Funder
    National Health and Medical Research Council
    Funding Amount
    $34,276.00
    More information
    Funded Activity

    Inactivation Of The Patched Tumour Suppressor Gene In The Skin Of Transgenic Mice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $164,967.00
    More information
    Funded Activity

    New Immunosuppressive Agents For Transplantation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $41,748.00
    More information
    Funded Activity

    Functional MRI And MR Spectroscopic Studies Of Penicillin Induced And Kindled Sheep Models Of Epilepsy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $311,244.00
    Summary
    Epilepsy is one of the most common neurological disorders, affecting 1-2% of the population. Many epilepsy patients do not respond to drug therapy and their only hope for seizure control is surgical removal of the part of the brain responsible for their seizures. Successful surgery is very much dependent on the ability to exactly localize the seizure focus and this is often not possible using the imaging techniques currently available. Functional magnetic resonance imaging (fMRI) is a new techni .... Epilepsy is one of the most common neurological disorders, affecting 1-2% of the population. Many epilepsy patients do not respond to drug therapy and their only hope for seizure control is surgical removal of the part of the brain responsible for their seizures. Successful surgery is very much dependent on the ability to exactly localize the seizure focus and this is often not possible using the imaging techniques currently available. Functional magnetic resonance imaging (fMRI) is a new technique which may improve our ability to localize the seizure focus from which seizures arise, if the brain can be imaged at, or near, the time of a seizure. MR spectroscopy (MRS) enables us to detect metabolic changes in the brain which may persist at the site where seizures have begun for up to 30 minutes after the seizure. The aim of our research is to obtain a greater understanding of the changes detected with these MR modalities so that we can learn to apply these techniques to human sufferers of epilepsy. Ultimately it may help enable previously incurable epilepsy patients to undergo successful surgery and live normal lives.
    Read more Read less
    More information
    Funded Activity

    Neurochemistry Of The Normal And Degenerating Mouse Retina

    Funder
    National Health and Medical Research Council
    Funding Amount
    $197,131.00
    More information

    Showing 1-10 of 154 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback